ArticleCellular oncology (Dordrecht, Netherlands)2018

A new ETV6-NTRK3 cell line model reveals MALAT1 as a novel therapeutic target - a short report.

Suning Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.